A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
NCT02489201
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class
Stopped
Corporate policy adjustments
Conditions
Oesophageal Cancer
Interventions
DRUG:
donafenib tosilate tablets
Sponsor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd